Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP in Cystic Fibrosis
NCT00125346Phase 3Terminated
- Sponsor
- Novartis
- Start
- Sep 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of tobramycin in cystic fibrosis (CF), sponsored by Novartis. Started Sep 2005; status: terminated.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00125346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125346.